Pathway Category Top Level |
Pathway Category Second Level |
Pathway ID |
Pathway Name |
p-Value |
Adjusted p-Value |
Enriched Genes |
09160 Human Diseases |
09166 Endocrine and metabolic diseases |
hsa04930 |
Type II diabetes mellitus |
2.400E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09161 Cancers |
hsa05210 |
Colorectal cancer |
3.100E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09161 Cancers |
hsa05212 |
Pancreatic cancer |
3.300E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09151 Immune system |
hsa04664 |
Fc epsilon RI signaling pathway |
3.400E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09151 Immune system |
hsa04621 |
NOD-like receptor signaling pathway |
2.850E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05120 |
Epithelial cell signaling in Helicobacter pylori infection |
3.400E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09152 Endocrine system |
hsa04917 |
Prolactin signaling pathway |
3.600E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05131 |
Shigellosis |
3.250E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09152 Endocrine system |
hsa04920 |
Adipocytokine signaling pathway |
3.500E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09157 Sensory system |
hsa04750 |
Inflammatory mediator regulation of TRP channels |
4.900E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09166 Endocrine and metabolic diseases |
hsa04933 |
AGE-RAGE signaling pathway in diabetic complications |
5.050E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09152 Endocrine system |
hsa04912 |
GnRH signaling pathway |
4.550E-03 |
9.594E-03 |
MAPK9 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04012 |
ErbB signaling pathway |
4.350E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09151 Immune system |
hsa04622 |
RIG-I-like receptor signaling pathway |
3.500E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09152 Endocrine system |
hsa04914 |
Progesterone-mediated oocyte maturation |
4.900E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05133 |
Pertussis |
3.750E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09161 Cancers |
hsa05231 |
Choline metabolism in cancer |
5.050E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05132 |
Salmonella infection |
4.300E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09156 Nervous system |
hsa04723 |
Retrograde endocannabinoid signaling |
5.050E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09151 Immune system |
hsa04660 |
T cell receptor signaling pathway |
5.200E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09151 Immune system |
hsa04620 |
Toll-like receptor signaling pathway |
5.300E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05142 |
Chagas disease (American trypanosomiasis) |
5.200E-03 |
9.594E-03 |
MAPK9 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04668 |
TNF signaling pathway |
5.500E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09166 Endocrine and metabolic diseases |
hsa04931 |
Insulin resistance |
5.450E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05145 |
Toxoplasmosis |
5.900E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09156 Nervous system |
hsa04722 |
Neurotrophin signaling pathway |
6.000E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09156 Nervous system |
hsa04728 |
Dopaminergic synapse |
6.450E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09158 Development |
hsa04380 |
Osteoclast differentiation |
6.600E-03 |
9.594E-03 |
MAPK9 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04071 |
Sphingolipid signaling pathway |
6.000E-03 |
9.594E-03 |
MAPK9 |
09140 Cellular Processes |
09143 Cell growth and death |
hsa04210 |
Apoptosis |
7.000E-03 |
9.594E-03 |
MAPK9 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04068 |
FoxO signaling pathway |
6.650E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05160 |
Hepatitis C |
6.650E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05161 |
Hepatitis B |
7.300E-03 |
9.594E-03 |
MAPK9 |
09160 Human Diseases |
09166 Endocrine and metabolic diseases |
hsa04932 |
Non-alcoholic fatty liver disease (NAFLD) |
7.550E-03 |
9.647E-03 |
MAPK9 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04310 |
Wnt signaling pathway |
7.100E-03 |
9.594E-03 |
MAPK9 |
09150 Organismal Systems |
09152 Endocrine system |
hsa04910 |
Insulin signaling pathway |
6.950E-03 |
9.594E-03 |
MAPK9 |